- Home
- QMCO vs CRDL Comparison
QMCO vs CRDL Comparison
Compare QMCO & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QMCO
- CRDL
- Stock Information
- Founded
- QMCO 1980
- CRDL 2017
- Country
- QMCO United States
- CRDL Canada
- Employees
- QMCO N/A
- CRDL N/A
- Industry
- QMCO Electronic Components
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- QMCO Technology
- CRDL Health Care
- Exchange
- QMCO Nasdaq
- CRDL Nasdaq
- Market Cap
- QMCO 123.4M
- CRDL 102.0M
- IPO Year
- QMCO N/A
- CRDL N/A
- Fundamental
- Price
- QMCO $15.16
- CRDL $1.20
- Analyst Decision
- QMCO Hold
- CRDL Strong Buy
- Analyst Count
- QMCO 3
- CRDL 3
- Target Price
- QMCO $19.00
- CRDL $9.00
- AVG Volume (30 Days)
- QMCO 1.3M
- CRDL 274.8K
- Earning Date
- QMCO 02-12-2025
- CRDL 03-31-2025
- Dividend Yield
- QMCO N/A
- CRDL N/A
- EPS Growth
- QMCO N/A
- CRDL N/A
- EPS
- QMCO N/A
- CRDL N/A
- Revenue
- QMCO $285,865,000.00
- CRDL N/A
- Revenue This Year
- QMCO N/A
- CRDL N/A
- Revenue Next Year
- QMCO $2.46
- CRDL N/A
- P/E Ratio
- QMCO N/A
- CRDL N/A
- Revenue Growth
- QMCO N/A
- CRDL N/A
- 52 Week Low
- QMCO $2.22
- CRDL $1.15
- 52 Week High
- QMCO $90.64
- CRDL $3.12
- Technical
- Relative Strength Index (RSI)
- QMCO 37.77
- CRDL 41.60
- Support Level
- QMCO $14.57
- CRDL $1.15
- Resistance Level
- QMCO $17.40
- CRDL $1.51
- Average True Range (ATR)
- QMCO 2.52
- CRDL 0.10
- MACD
- QMCO -0.26
- CRDL -0.01
- Stochastic Oscillator
- QMCO 5.42
- CRDL 13.65
About QMCO Quantum Corporation
Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data. The company provides solutions for the entire data lifecycle. The company specialize in solutions for video, images, audio, and other large files. The company's portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The company's Primary Storage Software and Systems include Myriad All-Flash Software-Defined Storage, StorNext Hybrid Flash/Disk File Storage Software, and Unified Surveillance Platform Software. Secondary Storage Software and Systems include ActiveScale Object Storage Software and DXi Backup Appliances. The firm derives the majority of its revenue from United States.
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.